PARP1-Driven Apoptosis in Chronic Lymphocytic Leukemia

<table>Pre- and posttreatment immunobloting results for 2 patients (A and B). Patient A expresses different levels of the full length (116 kDa) and the 89 kDa fragment of PARP1. Patient B expresses both the full length and the 89 kDa fragment of PARP1 before treatment but loses the full length molecule after immunochemotherapy.</table>

BioMed Research International

fig1

Figure 1

Figure 1: PARP1-Driven Apoptosis in Chronic Lymphocytic Leukemia 